BioHealth News Archive
FDA Grants Orphan Drug Designation (ODD) Status to NeoImmuneTech’s NT-I7 for Advanced Pancreatic Cancer Treatment
ROCKVILLE, Md., Jan. 30, 2024 /PRNewswire/ -- NeoImmuneTech, Inc. (NIT), a T cell-focused therapeutics company, today announced that the U.S. Food and Drug Administration (FDA) has…
Read More
Infinity Bio Launches Next-Generation Antibody Profiling Platform Utilizing MIPSA Technology
BALTIMORE--(BUSINESS WIRE)--Infinity Bio, Inc. announces its new antibody profiling platform, leveraging Molecular Indexing of Proteins by Self-Assembly (MIPSA) technology. This platform offers unparalleled depth…
Read More
Revolo Biotherapeutics Receives Orphan Drug Designation from the U.S. FDA for its First-in-Class Peptide as a Potential Treatment for Eosinophilic Esophagitis
GAITHERSBURG, Md. and CAMBRIDGE, United Kingdom, Jan. 30, 2024 (GLOBE NEWSWIRE) -- Revolo Biotherapeutics (“Revolo” or the “Company”), a company developing therapies that reset…
Read More
MaxCyte and Wugen Sign Strategic Platform License to Expedite Scale-Up of Clinical and Commercial Manufacturing of Wugen’s Investigational Allogeneic, Off-the-Shelf Cell Therapies for Cancers
ROCKVILLE, Md. and ST. LOUIS, Jan. 30, 2024 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (Nasdaq: MXCT; LSE: MXCT), a leading cell-engineering focused company providing enabling platform…
Read More
Calling all MedTech innovators: Up to $100,000 in federal grants to be awarded
Application deadline is Feb. 15 for the pandemic network edition of “Make Your Medical Device Pitch for Kids!™ WASHINGTON, Jan. 29, 2024 (GLOBE NEWSWIRE)…
Read More
The Daily Record: New Johns Hopkins institute aims to make Baltimore an AI hub
Johns Hopkins University has launched an ambitious endeavor that the school’s leaders say will make Baltimore a hub of the booming artificial intelligence industry.…
Read More
PQE Group: 100+M€ In Revenues, Expansion In Emerging Markets and Business Lines
Florence, Jan. 26, 2024 – PQE Group, the renowned Life Science consulting powerhouse, concludes the fiscal year 2023 with a 10% growth and an…
Read More
First Patient Enrolled in Rockville’s Rise Therapeutics’ Rheumatoid Arthritis Clinical Trial
ROCKVILLE, Md., Jan. 29, 2024 /PRNewswire/ -- Rise Therapeutics, a clinical-stage biotechnology company developing novel oral immunotherapeutic medicines, today announced that it has enrolled its first…
Read More
QIAGEN announces partnership with Penn State University to advance microbiome sciences
Germantown, Maryland, and State College, Pennsylvania, Jan. 25, 2024 (GLOBE NEWSWIRE) -- QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced a first-in-kind collaboration…
Read More
MaxCyte Signs Strategic Platform License with Imugene to Advance their Cancer Immunotherapy Programs
ROCKVILLE, Md., and SYDNEY, Australia, Jan. 23, 2024 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (Nasdaq: MXCT; LSE: MXCT), a leading, cell-engineering focused company providing enabling platform…
Read More
Technical.ly: ETC, One of Baltimore’s Oldest Entrepreneurship Incubators, Names Arti Santhanam as New Executive Director
After a period of leadership transition and strategic planning, the organizations behind one of Baltimore’s longest-standing entrepreneurial communities have appointed a new executive director…
Read More
Haystack Oncology and TriSalus Life Sciences Enter Research Collaboration
BALTIMORE, Jan. 22, 2024 /PRNewswire/ -- Haystack Oncology, a Quest Diagnostics (NYSE: DGX) company and developer of best-in-class personalized MRD technology (Haystack MRD™), has entered a research…
Read More
UMB Researchers Aim to Enhance Vaccines with $9.4M NIH Grant
January 16, 2024 - By Laura Lee - Principal Investigator Robert K. Ernst, PhD, the Dr. Paul and Mrs. Jean Corcoran Endowed Professor and chair of the Department of Microbial…
Read More
STEMCELL Technologies Announces Acquisition of Gaithersburg’s Propagenix Inc.
VANCOUVER, British Columbia--(BUSINESS WIRE)--STEMCELL Technologies, Canada’s largest biotechnology company, is pleased to announce the acquisition of Propagenix Inc.—a Maryland-based biotechnology company focused on developing…
Read More
Genetic Engineering & Biotechnology News: AI in Drug Discovery: Trust, but Verify
Tiffany Yesavage, PhD - January 11, 2024 - The use of artificial intelligence (AI) to develop new drugs is in its infancy. Nevertheless, AI-designed drugs have…
Read More